These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19857971)

  • 21. Receptor binding characteristics of the endocrine disruptor bisphenol A for the human nuclear estrogen-related receptor gamma. Chief and corroborative hydrogen bonds of the bisphenol A phenol-hydroxyl group with Arg316 and Glu275 residues.
    Liu X; Matsushima A; Okada H; Tokunaga T; Isozaki K; Shimohigashi Y
    FEBS J; 2007 Dec; 274(24):6340-51. PubMed ID: 18005256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in the mutagenic and estrogenic activities of bisphenol A upon treatment with nitrite.
    Masuda S; Terashima Y; Sano A; Kuruto R; Sugiyama Y; Shimoi K; Tanji K; Yoshioka H; Terao Y; Kinae N
    Mutat Res; 2005 Aug; 585(1-2):137-46. PubMed ID: 15936980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor.
    Schmidt JM; Mercure J; Tremblay GB; Pagé M; Kalbakji A; Feher M; Dunn-Dufault R; Peter MG; Redden PR
    J Med Chem; 2003 Apr; 46(8):1408-18. PubMed ID: 12672240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of analogs of indole-3-carbinol cyclic trimerization product in human breast cancer cells.
    Xue L; Schaldach CM; Janosik T; Bergman J; Bjeldanes LF
    Chem Biol Interact; 2005 Apr; 152(2-3):119-29. PubMed ID: 15840385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of carborane-containing estrogen receptor-beta (ERβ)-selective ligands.
    Ohta K; Ogawa T; Oda A; Kaise A; Endo Y
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4174-8. PubMed ID: 26298498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship.
    Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Kato N; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Morikawa K; Jo JC; Lim HS; Kim HY
    Bioorg Med Chem; 2006 Jul; 14(14):4803-19. PubMed ID: 16580210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties.
    Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL
    J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogenic activity of bis(4-hydroxyphenyl)methanes with cyclic hydrophobic structure.
    Kojima T; Ogawa T; Kitao S; Sato M; Oda A; Ohta K; Endo Y
    Bioorg Med Chem; 2015 Nov; 23(21):6900-11. PubMed ID: 26462053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzoxepin-derived estrogen receptor modulators: a novel molecular scaffold for the estrogen receptor.
    Lloyd DG; Hughes RB; Zisterer DM; Williams DC; Fattorusso C; Catalanotti B; Campiani G; Meegan MJ
    J Med Chem; 2004 Nov; 47(23):5612-5. PubMed ID: 15509159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oestrogenic activity of benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) in MCF7 human breast cancer cells in vitro.
    Charles AK; Darbre PD
    J Appl Toxicol; 2009 Jul; 29(5):422-34. PubMed ID: 19338011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, in vitro antiviral evaluation, and stability studies of novel alpha-borano-nucleotide analogues of 9-[2-(phosphonomethoxy)ethyl]adenine and (R)-9-[2-(phosphonomethoxy)propyl]adenine.
    Barral K; Priet S; Sire J; Neyts J; Balzarini J; Canard B; Alvarez K
    J Med Chem; 2006 Dec; 49(26):7799-806. PubMed ID: 17181162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM; ter Laak AM; Jongejan A; Vermeulen NP; Wamelink M; Geerke D; Meerman JH
    J Med Chem; 2004 Feb; 47(4):1018-30. PubMed ID: 14761204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent estrogen receptor ligands based on bisphenols with a globular hydrophobic core.
    Endo Y; Yoshimi T; Ohta K; Suzuki T; Ohta S
    J Med Chem; 2005 Jun; 48(12):3941-4. PubMed ID: 15943468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-estrogenic effects of conjugated linoleic acid through modulation of estrogen receptor phosphorylation.
    Liu J; Sidell N
    Breast Cancer Res Treat; 2005 Nov; 94(2):161-9. PubMed ID: 16261415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphine boranes as less hydrophobic building blocks than alkanes and silanes: Structure-property relationship and estrogen-receptor-modulating potency of 4-phosphinophenol derivatives.
    Saito H; Matsumoto Y; Hashimoto Y; Fujii S
    Bioorg Med Chem; 2020 Feb; 28(4):115310. PubMed ID: 31980362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of molecular and structural determinants of selective estrogen receptor downregulators.
    Fan M; Rickert EL; Chen L; Aftab SA; Nephew KP; Weatherman RV
    Breast Cancer Res Treat; 2007 May; 103(1):37-44. PubMed ID: 17033922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo estrogenic activity of chlorinated derivatives of bisphenol A.
    Takemura H; Ma J; Sayama K; Terao Y; Zhu BT; Shimoi K
    Toxicology; 2005 Feb; 207(2):215-21. PubMed ID: 15596252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.